SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : CYTC - How High Can It Go!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Philip Hager who wrote (28)6/22/1997 11:20:00 AM
From: Ted Downs   of 185
 
The thin prep pap test is much more accurate than the conventional pap smear. The fact that Mead Johnson is selling the test through their sales force and Jun 19th Quest Diagostics Inc. announced their labs have a longterm agreement to use the test means that Cytyc has finally taken off IMHO. The only fly in the ointment seems to be whether the insurance community will resist the additional cost. That could slow the acceptance somewhat but the trend in the health coverage field is preventive care so I think the difference in costs of tests will be outweighed by the accuracy and overall be cheaper in the longrun for the HMO's etc.
The stock appears to want to back off some with a short term sell by the stochastics reading, but the charts still look like their solid for a move into new high ground. Friday saw some resistance and it's due to about a 12 point move recently.

Good Luck,

Ted
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News